Varenicline in the treatment of tobacco dependence
Open Access
- 1 April 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in Neuropsychiatric Disease and Treatment
- Vol. 4 (2), 353-363
- https://doi.org/10.2147/ndt.s927
Abstract
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishingKeywords
This publication has 58 references indexed in Scilit:
- Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis.American Journal of Health Behavior, 2008
- Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illnessAddiction, 2007
- Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aidNeuropharmacology, 2007
- Effects of abstinence from tobacco: Valid symptoms and time courseNicotine & Tobacco Research, 2007
- Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking CessationA Randomized Controlled TrialPublished by American Medical Association (AMA) ,2006
- The neurobiological basis for partial agonist treatment of nicotine dependence: vareniclineInternational Journal of Clinical Practice, 2006
- Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001.2005
- Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)Neuropsychopharmacology, 2004
- Chapter 27 Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigationsProgress in Brain Research, 1989
- Human Pharmacology and Abuse Potential of the Analgesic BuprenorphineArchives of General Psychiatry, 1978